These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 31047733)

  • 1. Role of Core Number and Location in Targeted Magnetic Resonance Imaging-Ultrasound Fusion Prostate Biopsy.
    Lu AJ; Syed JS; Ghabili K; Hsiang WR; Nguyen KA; Leapman MS; Sprenkle PC
    Eur Urol; 2019 Jul; 76(1):14-17. PubMed ID: 31047733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimizing the Number of Cores Targeted During Prostate Magnetic Resonance Imaging Fusion Target Biopsy.
    Kenigsberg AP; Renson A; Rosenkrantz AB; Huang R; Wysock JS; Taneja SS; Bjurlin MA
    Eur Urol Oncol; 2018 Oct; 1(5):418-425. PubMed ID: 31158081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative analysis of transperineal template saturation prostate biopsy versus magnetic resonance imaging targeted biopsy with magnetic resonance imaging-ultrasound fusion guidance.
    Radtke JP; Kuru TH; Boxler S; Alt CD; Popeneciu IV; Huettenbrink C; Klein T; Steinemann S; Bergstraesser C; Roethke M; Roth W; Schlemmer HP; Hohenfellner M; Hadaschik BA
    J Urol; 2015 Jan; 193(1):87-94. PubMed ID: 25079939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging and Fusion Guided Targeted Biopsy Evaluated by Transperineal Template Saturation Prostate Biopsy for the Detection and Characterization of Prostate Cancer.
    Mortezavi A; Märzendorfer O; Donati OF; Rizzi G; Rupp NJ; Wettstein MS; Gross O; Sulser T; Hermanns T; Eberli D
    J Urol; 2018 Aug; 200(2):309-318. PubMed ID: 29474846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How Many Targeted Biopsy Cores are Needed for Clinically Significant Prostate Cancer Detection during Transperineal Magnetic Resonance Imaging Ultrasound Fusion Biopsy?
    Song G; Ruan M; Wang H; Fan Y; He Q; Lin Z; Li X; Li P; Wang X; He Z; Zhou L
    J Urol; 2020 Dec; 204(6):1202-1208. PubMed ID: 32716686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Systematic and Targeted Biopsies in Light of Overlap on Magnetic Resonance Imaging Ultrasound Fusion Biopsy.
    Patel N; Cricco-Lizza E; Kasabwala K; Xu C; Robinson BD; Khani F; Wang Y; Margolis D; Hu JC
    Eur Urol Oncol; 2018 Sep; 1(4):263-267. PubMed ID: 31100246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced Core Targeted (RCT) biopsy: Combining multiparametric magnetic resonance imaging - transrectal ultrasound fusion targeted biopsy with laterally-directed sextant biopsies - An alternative template for prostate fusion biopsy.
    Aminsharifi A; Gupta RT; Tsivian E; Sekar S; Sze C; Polascik TJ
    Eur J Radiol; 2019 Jan; 110():7-13. PubMed ID: 30599876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiparametric Magnetic Resonance Imaging/Ultrasound Fusion Prostate Biopsy-Are 2 Biopsy Cores per Magnetic Resonance Imaging Lesion Required?
    Dimitroulis P; Rabenalt R; Nini A; Hiester A; Esposito I; Schimmöller L; Antoch G; Albers P; Arsov C
    J Urol; 2018 Nov; 200(5):1030-1034. PubMed ID: 29733837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnostic efficacy of targeted biopsy combined with regional systematic biopsy in prostate cancer in patients with PI-RADS 4-5].
    Yao K; Ruan M; Li D; Tian Y; Chen Y; Fan Y; Liu Y
    Beijing Da Xue Xue Bao Yi Xue Ban; 2024 Aug; 56(4):575-581. PubMed ID: 39041548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of Clinically Significant Prostate Cancer Using Magnetic Resonance Imaging-Ultrasound Fusion Targeted Biopsy: A Systematic Review.
    Valerio M; Donaldson I; Emberton M; Ehdaie B; Hadaschik BA; Marks LS; Mozer P; Rastinehad AR; Ahmed HU
    Eur Urol; 2015 Jul; 68(1):8-19. PubMed ID: 25454618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of Gleason 6 prostate cancer in patients with clinically significant prostate cancer on multiparametric magnetic resonance imaging.
    Chaloupka M; Bischoff R; Pfitzinger P; Lellig E; Ledderose S; Buchner A; Schlenker B; Stief C; Clevert DA; Apfelbeck M
    Clin Hemorheol Microcirc; 2019; 73(1):105-111. PubMed ID: 31561351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Added Value of Multiparametric Ultrasonography in Magnetic Resonance Imaging and Ultrasonography Fusion-guided Biopsy of the Prostate in Patients With Suspicion for Prostate Cancer.
    Maxeiner A; Stephan C; Durmus T; Slowinski T; Cash H; Fischer T
    Urology; 2015 Jul; 86(1):108-14. PubMed ID: 26142593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective, blinded comparison of magnetic resonance (MR) imaging-ultrasound fusion and visual estimation in the performance of MR-targeted prostate biopsy: the PROFUS trial.
    Wysock JS; Rosenkrantz AB; Huang WC; Stifelman MD; Lepor H; Deng FM; Melamed J; Taneja SS
    Eur Urol; 2014 Aug; 66(2):343-51. PubMed ID: 24262102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic resonance imaging/transrectal ultrasound fusion-targeted prostate biopsy using three-dimensional ultrasound-based organ-tracking technology: Initial experience in Japan.
    Yamada Y; Fujihara A; Shiraishi T; Ueda T; Yamada T; Ueno A; Inoue Y; Kaneko M; Kamoi K; Hongo F; Okihara K; Ukimura O
    Int J Urol; 2019 May; 26(5):544-549. PubMed ID: 30793385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiparametric MRI-ultrasonography software fusion prostate biopsy: initial results using a stereotactic robotic-assisted transperineal prostate biopsy platform comparing systematic vs targeted biopsy.
    Lee AYM; Yang XY; Lee HJ; Law YM; Huang HH; Lau WKO; Lee LS; Ho HSS; Tay KJ; Cheng CWS; Yuen JSP; Chen K
    BJU Int; 2020 Nov; 126(5):568-576. PubMed ID: 32438463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transperineal Multiparametric Magnetic Resonance Imaging-Ultrasound Fusion Targeted Prostate Biopsy Combined with Standard Template Improves Prostate Cancer Detection.
    Kim MM; Wu S; Lin SX; Crotty RK; Harisinghani M; Feldman AS; Wu CL; Dahl DM
    J Urol; 2022 Jan; 207(1):86-94. PubMed ID: 34428921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimizing Spatial Biopsy Sampling for the Detection of Prostate Cancer.
    Raman AG; Sarma KV; Raman SS; Priester AM; Mirak SA; Riskin-Jones HH; Dhinagar N; Speier W; Felker E; Sisk AE; Lu D; Kinnaird A; Reiter RE; Marks LS; Arnold CW
    J Urol; 2021 Sep; 206(3):595-603. PubMed ID: 33908801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimum Magnetic Resonance Imaging-Ultrasound Fusion Targeted Biopsy Cores Needed for Prostate Cancer Detection: Multivariable Retrospective, Lesion Based Analyses of Patients Treated with Radical Prostatectomy.
    Leyh-Bannurah SR; Kachanov M; Beyersdorff D; Tian Z; Karakiewicz PI; Tilki D; Fisch M; Maurer T; Graefen M; Budäus L
    J Urol; 2020 Feb; 203(2):299-303. PubMed ID: 31483694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship Between Prebiopsy Multiparametric Magnetic Resonance Imaging (MRI), Biopsy Indication, and MRI-ultrasound Fusion-targeted Prostate Biopsy Outcomes.
    Meng X; Rosenkrantz AB; Mendhiratta N; Fenstermaker M; Huang R; Wysock JS; Bjurlin MA; Marshall S; Deng FM; Zhou M; Melamed J; Huang WC; Lepor H; Taneja SS
    Eur Urol; 2016 Mar; 69(3):512-7. PubMed ID: 26112001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate cancer detection on transrectal ultrasonography-guided random biopsy despite negative real-time magnetic resonance imaging/ultrasonography fusion-guided targeted biopsy: reasons for targeted biopsy failure.
    Cash H; Günzel K; Maxeiner A; Stephan C; Fischer T; Durmus T; Miller K; Asbach P; Haas M; Kempkensteffen C
    BJU Int; 2016 Jul; 118(1):35-43. PubMed ID: 26384851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.